Pharmaceutical Sciences Laboratory, Faculty of Science and Engineering, Abo Akademi University, BioCity, Artillerigatan 6 A, FI-20520 Turku, Finland.
Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, FI-00014 Helsinki, Finland.
Eur J Med Chem. 2015 Sep 18;102:68-79. doi: 10.1016/j.ejmech.2015.07.038. Epub 2015 Jul 21.
The combination of the dehydroabietic acid scaffold with different amino acids resulted in the discovery of a new class of hybrid compounds that targets both planktonic and biofilms bacteria in Staphylococcus aureus strains and are far more potent anti-biofilm agents than conventional antibiotics. Unlike dehydroabietic acid, these compounds can disrupt biofilms within a short time period and compromise the integrity of the bacterial membrane. Two of the compounds identified in our study are the most potent abietane-type anti-biofilm agents reported so far and display robust activity against pre-formed biofilms at concentrations only 3-6-fold higher than those required to inhibit biofilm formation. Their easy preparation based on proteolysis-resistant d- and unusual amino acids makes them useful chemical probes to gain a deeper understanding of bacterial biofilms and outstanding candidates for further development into new drugs to fight infections.
将去氢枞酸骨架与不同的氨基酸结合,发现了一类新的杂合化合物,它们可以靶向金黄色葡萄球菌中的浮游菌和生物膜菌,并且比传统抗生素具有更强的抗生物膜活性。与去氢枞酸不同,这些化合物可以在短时间内破坏生物膜,并破坏细菌膜的完整性。在我们的研究中确定的两种化合物是迄今为止报道的最有效的扁柏烷型抗生物膜剂,并且在浓度仅比抑制生物膜形成所需的浓度高 3-6 倍的情况下,对预先形成的生物膜显示出强大的活性。它们基于蛋白酶抗性的 d-和不常见氨基酸的易于制备,使它们成为研究细菌生物膜的有用化学探针,并成为进一步开发用于抗感染的新药的优秀候选者。